Intermittent Fasting in Diabetes

Food & Nutrition, Living With Diabetes

For those living with Type 2 diabetes the benefits of reducing calories in the diet, weight loss and lower blood sugar, are well known.  While controlling diet is important, strict low-calorie diets can be difficult to maintain for long periods of time. Simply reducing calories may also not be the most effective way to lose […]


Loop Installation @ BC Diabetes

Living With Diabetes, Patient Care + Research + Clinical Trials, Technology

The Artificial Pancreas (automated insulin delivery, AID) is here and we are not waiting! On 2020-Aug-1 BCDiabetes began doing in-house installations of the Omnipod Eros-Dexcom G6-Riley link Loop system (using the Master branch with Autobolus option = “Pete’s).  Although this system is not Health Canada approved, it is our default recommendation.  This is because currently […]


Eligible: How To Get Your COVID-19 Vaccine

News & Media, Patient Care + Research + Clinical Trials

Dr. Elliott and the entire staff at BC Diabetes are delighted to report that COVID-19 vaccines are being made available to all British Columbians who are taking insulin. On Tuesday, March 23rd, 2021, the Government of British Columbia put out a statement saying that people who were “clinically extremely vulnerable” were now eligible to receive […]


PharmaCare Covered: Ozempic (Semaglutide) by Novo Nordisk

Announcements, Living With Diabetes, News & Media

Big news today for the 200,000 British Columbians living with Type 2 diabetes who are overweight or who have a history of heart attack or stroke.  Today BC Pharmacare announced coverage of semaglutide (“Ozempic”), a once-a-week shot, for individuals living with Type 2 diabetes on oral medication alone (metformin & glyburide) or on insulin plus […]


Nightscout: the 2020 Diabetes Revolution

Patient Care + Research + Clinical Trials, Technology

In 2018 with the arrival in Canada of continuous glucose monitors (CGM) a diabetes revolution began.  CGM meant no more finger pricking, no fear of going low overnight; vastly improved glucose control and a future without the dreaded long-term complications of diabetes. The revolution continued in early 2020 with the artificial pancreas being made possible […]


The Three Hottest Words in Diabetes: Loop, Looper & Looping

Living With Diabetes, News & Media, Technology

The three hottest words in Type 1 diabetes these days are “loop”, “looper” & “looping”.  These refer to the groundbreaking revolutionary open source software implementation of the Artificial Pancreas, the technological cure of Type 1 diabetes.  Loopers are Type 1s who use the Loop app running on an iPhone to control their insulin pump based […]


Testimonial: CGM Is A Game Changer

Living With Diabetes, Technology

My name is Tyler Craig, and I am a patient at BC Diabetes. I would like to add my voice to Dr. Elliott’s and his team’s advocacy efforts to have universal coverage for CGM (continuous glucose monitoring) devices. I am grateful that BC Diabetes introduced me to the CGM device as it has been a […]


CGM Campaign

Living With Diabetes, Patient Care + Research + Clinical Trials

Continuous Glucose Monitoring, known as CGM, allows for the automatic tracking of glucose (sugar) levels for people living with Type 1 Diabetes (TID).  Keeping sugar levels within a safe & healthy target range (5-10 mmol/L) is crucial to prevent the dreaded diabetes complications of loss of consciousness, heart disease & stroke, blindness, kidney failure and […]


Information for patients regarding COVID-19 response at BC Diabetes

Announcements, News & Media

BCDiabetes is committed to providing the highest quality diabetes care to all British Columbians. With the situation involving novel coronavirus (COVID-19) changing quickly, we reassure you that we are continuing to operate and provide services, while monitoring recommendations from the US CDC and Health Canada. However, we are also mindful of concerns that you might […]


BC Pharmacare to cover SGLT-2 inhibitors and to delist the Lantus brand of insulin glargine U100

Announcements, Living With Diabetes

Yesterday BC Minister of Health Adrian Dix announced Pharmacare coverage of the SGLT-2 inhibitor class represented by empagliflozin (Jardiance). Although BCDiabetes would have preferred that all three SGLT2 inhibitors on the Canadian market be covered, the long overdue announcement was most welcome news. Our readers will be aware of the long-running BCDiabetes advocacy campaign for […]

Translate »